| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.09 | 0.003 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.003 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.004 |